TIDMSPH

RNS Number : 6073A

Sinclair Pharma PLC

27 March 2017

Sinclair Pharma plc

Appointment of Joint Broker

London, 27 March 2017 Sinclair Pharma plc (SPH.L), ("Sinclair") the international Aesthetics company, announces the appointment of RBC Capital Markets to act as its joint broker alongside Peel Hunt LLP, with immediate effect.

For further information please contact:

 
 Sinclair Pharma plc   Tel: +44 (0) 20 7467 6920 
 Chris Spooner 
  Alan Olby 
  Andy Crane 
 
 
 Peel Hunt LLP (NOMAD and   Tel: +44 (0) 20 7418 8900 
  Joint Broker) 
 James Steel 
  Oliver Jackson 
 
 
 RBC Capital Markets (Joint   Tel: +44 (0) 20 7653 4000 
  Broker) 
 Marcus Jackson 
  Laura White

Media enquiries

 
 FTI Consulting        Tel: +44 (0) 203 727 1000 
 Ben Atwell 
  Brett Pollard 
  Stephanie Cuthbert

Notes to Editors:

About Sinclair Pharma plc

Sinclair Pharma plc is an international company operating in the fast growth, high gross margin, global aesthetics market. Sinclair has built a strong portfolio of differentiated, complementary aesthetics technologies, which are experiencing significant growth, targeting unmet clinical needs for effective, high quality, longer duration, natural looking and minimally-invasive treatments. The Company is planning entry to multiple new geographic markets and line extension launches over the next few years. Sinclair has an established sales and marketing presence in the leading EU markets and Brazil, and a network of international distributors.

For more information, please visit

www.sinclairpharma.com

This information is provided by RNS

The company news service from the London Stock Exchange

END

APPGCGDXCBDBGRR

(END) Dow Jones Newswires

March 27, 2017 05:30 ET (09:30 GMT)

Sinclair Pharma (LSE:SPH)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Sinclair Pharma Charts.
Sinclair Pharma (LSE:SPH)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Sinclair Pharma Charts.